spacer
home > ict > autumn 2020 > improving clinical trial outcomes using ai and automation
PUBLICATIONS
International Clinical Trials

Improving Clinical Trial Outcomes Using AI and Automation

Now, more than ever, the healthcare industry is searching for ways to live by the ‘work smarter, not harder’ motto. The first few months of the global pandemic certainly pushed pharmaceutical companies to reevaluate how to conduct clinical trials. Then and now, all aspects of clinical development are being reviewed to improve trial efficiencies. However, the truth is that addressing inefficiencies throughout the trial process to enhance clinical outcomes has been a focus for sponsors long before COVID-19. In an increasingly complex clinical development landscape, sponsors need to improve productivity and drive higher quality outcomes over accelerated trial timelines, while reducing costs, which is no easy feat. At the same time, it is essential to reduce the burden on patients and site teams.

Especially with unprecedented obstacles, like the pandemic, sponsors realise it is necessary to examine individual trial processes within the end-to-end model to address inefficiencies that inhibit productivity. Most organisations are turning to digital solutions, including artificial intelligence/machine learning (AI/ML), to digitise and modernise the clinical development process. This evolution allows sponsors and study teams to increase productivity by automating repetitive routine work they traditionally spend time and effort to complete. COVID-19 provided a catalyst for sponsors to investigate and adopt these solutions at scale.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Nagaraja Srivatsan ('Sri') is Senior Vice President and Chief Digital Officer, R&D Systems Technology Solutions at IQVIA. He is responsible for driving growth and leading product development and operations of R&D systems technologies. Nagaraja has over 30 years of experience in growing businesses in the digital, data, AI, analytics, IT, and operations management areas across several industry verticals. In 2010, he was recognised as one of the top 100 most inspiring people in the life sciences industry award by PharmaVOICE publication. www.linkedin.com/in/nagarajasrivatsan

Print this page
Send to a friend
Privacy statement
News and Press Releases

SHL attends the 2020 PDA in virtual fashion

SHL will join the 2020 Parenteral Drug Association’s annual Universe of Pre-Filled Syringes and Injection Devices virtual event with the launch of our virtual experience platform. Visitors can attend the event through the PDA’s online platform that comprises live chat sessions, conference presentations, and company pages.
More info >>

White Papers

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific.

Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement